Concentrix Corporation
CNXC
$47.10
$2.475.53%
| Weiss Ratings | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Fair | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.13 | |||
| Price History | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.65% | |||
| 30-Day Total Return | -9.62% | |||
| 60-Day Total Return | 9.51% | |||
| 90-Day Total Return | 4.24% | |||
| Year to Date Total Return | 8.85% | |||
| 1-Year Total Return | -27.25% | |||
| 2-Year Total Return | -64.15% | |||
| 3-Year Total Return | -73.82% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -42.04% | |||
| 52-Week Low % Change | 23.02% | |||
| Price | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $77.00 | |||
| 52-Week Low Price | $36.28 | |||
| 52-Week Low Price (Date) | Nov 19, 2024 | |||
| 52-Week High Price (Date) | Aug 28, 2024 | |||
| Valuation | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.87B | |||
| Enterprise Value | 8.24B | |||
| Price/Earnings (TTM) | 12.00 | |||
| Earnings Per Share (TTM) | 3.72 | |||
| Earnings Per Share Growth | -35.54% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.30 | |||
| Price/Book (Q) | 0.71 | |||
| Enterprise Value/Revenue (TTM) | 0.86 | |||
| Price | $47.10 | |||
| Enterprise Value/EBITDA (TTM) | 5.67 | |||
| Enterprise Value/EBIT | 11.04 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 64.35M | |||
| Dividend Yield | 3.52% | |||
| Div. Per Share (Most Recent) | $0.33 | |||
| Dividend Per Share (TTM) | $1.57 | |||
| Payout Ratio (TTM) | 33.36% | |||
| Dividend Per Share (Most Recent) | $0.33 | |||
| Company Info | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (800) 747-0583 | |||
| Address | 39899 Balentine Drive Newark, CA 94560 | |||
| Website | www.concentrix.com | |||
| Country | United States | |||
| Year Founded | 2004 | |||
| Profitability | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 7.75% | |||
| Profit Margin | 2.61% | |||
| Management Effectiveness | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.81% | |||
| Return on Equity | 6.14% | |||
| Income Statement | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 9.62B | |||
| Total Revenue (TTM) | 9.62B | |||
| Revenue Per Share | $149.47 | |||
| Gross Profit (TTM) | 3.45B | |||
| EBITDA (TTM) | 1.45B | |||
| EBIT (TTM) | 746.09M | |||
| Net Income (TTM) | 251.22M | |||
| Net Income Avl. to Common (TTM) | 251.22M | |||
| Total Revenue Growth (Q YOY) | 9.74% | |||
| Earnings Growth (Q YOY) | 66.43% | |||
| EPS Diluted (TTM) | 3.72 | |||
| EPS Diluted Growth (Q YOY) | 57.91% | |||
| Balance Sheet | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 240.57M | |||
| Cash Per Share (Q) | $3.74 | |||
| Total Current Assets (Q) | 2.84B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 4.04B | |||
| Current Ratio (Q) | 1.424 | |||
| Book Value Per Share (Q) | $62.89 | |||
| Total Assets (Q) | 11.99B | |||
| Total Current Liabilities (Q) | 2.00B | |||
| Total Debt (Q) | 5.60B | |||
| Total Liabilities (Q) | 7.95B | |||
| Total Common Equity (Q) | 4.04B | |||
| Cash Flow | CNXC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -244.27M | |||
| Cash from Financing (TTM) | -492.53M | |||
| Net Change in Cash (TTM) | -86.88M | |||
| Levered Free Cash Flow (TTM) | 729.57M | |||
| Cash from Operations (TTM) | 667.49M | |||
